Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 03, 2022

SELL
$72.5 - $100.68 $13,775 - $19,129
-190 Closed
0 $0
Q3 2021

Oct 19, 2021

SELL
$90.24 - $124.05 $118,304 - $162,629
-1,311 Reduced 87.34%
190 $18,000
Q2 2021

Jul 28, 2021

BUY
$93.66 - $139.27 $140,583 - $209,044
1,501 New
1,501 $186,000
Q3 2020

Nov 10, 2020

SELL
$72.92 - $102.01 $3,427 - $4,794
-47 Closed
0 $0
Q2 2020

Aug 10, 2020

BUY
$55.75 - $92.75 $2,620 - $4,359
47 New
47 $4.37 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Arkadios Wealth Advisors Portfolio

Follow Arkadios Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arkadios Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Arkadios Wealth Advisors with notifications on news.